{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:08:17Z","timestamp":1793160497753,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974390"],"award-info":[{"award-number":["81974390"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472953"],"award-info":[{"award-number":["82472953"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272884"],"award-info":[{"award-number":["82272884"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Malignant glioma is the most common primary malignant tumor of the brain in adults, with glioblastoma (GBM) being the most aggressive subtype. Mesenchymal stem\/stromal cells (MSCs) have been shown to fuse with tumor cells in various cancers including glioma, thereby regulating tumor progression. However, there has been no systematic research on the fusion of glioma-associated MSCs (GA-MSCs) with glioma cells. Here, it is shown that GA-MSCs are able to spontaneously fuse with glioma cells both in vitro and in vivo. The hybrid cells display significantly lower levels of N6-methyladenosine (m\n                    <jats:sup>6<\/jats:sup>\n                    A) modification and can modulate the glioma microenvironment by attracting and inducing M2-like polarization of macrophages. Mechanistically, the demethylase fat mass and obesity-associated protein (FTO) mediates demethylation in hybrids and promotes macrophage colony-stimulating factor (CSF1) secretion by increasing its RNA stability in an m\n                    <jats:sup>6<\/jats:sup>\n                    A-YTH domain family 2 (YTHDF2)-dependent manner. Our study reveals a novel crosstalk mechanism between glioma cells, GA-MSCs, and macrophages in glioma microenvironment, offering potential new approaches for glioma therapy.\n                  <\/jats:p>","DOI":"10.1038\/s41419-025-07678-x","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T10:05:59Z","timestamp":1745661959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Fusion of glioma-associated mesenchymal stem\/stromal cells with glioma cells promotes macrophage recruitment and M2 polarization via m6A modification of CSF1"],"prefix":"10.1038","volume":"16","author":[{"given":"Zhen","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujie","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zesheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haofei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8844-0286","authenticated-orcid":false,"given":"Xiaobing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,26]]},"reference":[{"key":"7678_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23:1231\u201351.","journal-title":"Neuro Oncol"},{"key":"7678_CR2","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1001\/jama.2017.18718","volume":"318","author":"R Stupp","year":"2017","unstructured":"Stupp R, Taillibert S, Kanner A, Read W, Steinberg D, Lhermitte B, et al. Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial. JAMA. 2017;318:2306\u201316.","journal-title":"JAMA"},{"key":"7678_CR3","doi-asserted-by":"crossref","unstructured":"Dapash M, Hou D, Castro B, Lee-Chang C, Lesniak MS. The Interplay between Glioblastoma and Its Microenvironment. Cells. 2021;10:2257.","DOI":"10.3390\/cells10092257"},{"key":"7678_CR4","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","volume":"31","author":"DF Quail","year":"2017","unstructured":"Quail DF, Joyce JA. The Microenvironmental Landscape of Brain Tumors. Cancer Cell. 2017;31:326\u201341.","journal-title":"Cancer Cell"},{"key":"7678_CR5","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1242\/jcs.02932","volume":"119","author":"L da Silva Meirelles","year":"2006","unstructured":"da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 2006;119:2204\u201313.","journal-title":"J Cell Sci"},{"key":"7678_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.pharmthera.2019.04.005","volume":"200","author":"P Li","year":"2019","unstructured":"Li P, Gong Z, Shultz LD, Ren G. Mesenchymal stem cells: From regeneration to cancer. Pharmacol Ther. 2019;200:42\u201354.","journal-title":"Pharmacol Ther"},{"key":"7678_CR7","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1093\/stmcls\/sxac036","volume":"40","author":"L Frisbie","year":"2022","unstructured":"Frisbie L, Buckanovich RJ, Coffman L. Carcinoma-Associated Mesenchymal Stem\/Stromal Cells: Architects of the Pro-tumorigenic Tumor Microenvironment. Stem Cells. 2022;40:705\u201315.","journal-title":"Stem Cells"},{"key":"7678_CR8","doi-asserted-by":"crossref","unstructured":"Clavreul A, Menei P. Mesenchymal Stromal-Like Cells in the Glioma Microenvironment: What Are These Cells? Cancers. 2020;12:2628.","DOI":"10.3390\/cancers12092628"},{"key":"7678_CR9","first-page":"660","volume":"19","author":"T Shahar","year":"2017","unstructured":"Shahar T, Rozovski U, Hess KR, Hossain A, Gumin J, Gao F, et al. Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival. Neuro Oncol. 2017;19:660\u20138.","journal-title":"Neuro Oncol"},{"key":"7678_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-016-0143-0","volume":"14","author":"C Melzer","year":"2016","unstructured":"Melzer C, Yang Y, Hass R. Interaction of MSC with tumor cells. Cell Commun Signal. 2016;14:20.","journal-title":"Cell Commun Signal"},{"key":"7678_CR11","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nrc1740","volume":"5","author":"R Bjerkvig","year":"2005","unstructured":"Bjerkvig R, Tysnes BB, Aboody KS, Najbauer J, Terzis AJA. The origin of the cancer stem cell: current controversies and new insights. Nature Rev Cancer. 2005;5:899\u2013904.","journal-title":"Nature Rev Cancer"},{"key":"7678_CR12","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S1535-6108(03)00114-4","volume":"3","author":"D Duelli","year":"2003","unstructured":"Duelli D, Lazebnik Y. Cell fusion: a hidden enemy?. Cancer Cell. 2003;3:445\u20138.","journal-title":"Cancer Cell"},{"key":"7678_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5306\/wjco.v11.i3.121","volume":"11","author":"I Shabo","year":"2020","unstructured":"Shabo I, Svanvik J, Lindstr\u00f6m A, Lechertier T, Trabulo S, Hulit J, et al. Roles of cell fusion, hybridization and polyploid cell formation in cancer metastasis. World J Clin Oncol. 2020;11:121\u201335.","journal-title":"World J Clin Oncol"},{"key":"7678_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/nrc2371","volume":"8","author":"JM Pawelek","year":"2008","unstructured":"Pawelek JM, Chakraborty AK. Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis. Nat Rev Cancer. 2008;8:377\u201386.","journal-title":"Nat Rev Cancer"},{"key":"7678_CR15","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1111\/febs.15483","volume":"288","author":"LN Zhang","year":"2021","unstructured":"Zhang LN, Zhang DD, Yang L, Gu YX, Zuo QP, Wang HY, et al. Roles of cell fusion between mesenchymal stromal\/stem cells and malignant cells in tumor growth and metastasis. FEBS J. 2021;288:1447\u201356.","journal-title":"FEBS J"},{"key":"7678_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6460-0","volume":"19","author":"C Sun","year":"2019","unstructured":"Sun C, Dai X, Zhao D, Wang H, Rong X, Huang Q, et al. Mesenchymal stem cells promote glioma neovascularization in vivo by fusing with cancer stem cells. BMC Cancer. 2019;19:1240.","journal-title":"BMC Cancer"},{"key":"7678_CR17","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.3892\/or.2015.4135","volume":"34","author":"C Sun","year":"2015","unstructured":"Sun C, Zhao D, Dai X, Chen J, Rong X, Wang H, et al. Fusion of cancer stem cells and mesenchymal stem cells contributes to glioma neovascularization. Oncol Rep. 2015;34:2022\u201330.","journal-title":"Oncol Rep"},{"key":"7678_CR18","doi-asserted-by":"publisher","first-page":"35344","DOI":"10.1021\/acsami.2c06658","volume":"14","author":"X Dai","year":"2022","unstructured":"Dai X, Shao Y, Tian X, Cao X, Ye L, Gao P, et al. Fusion between Glioma Stem Cells and Mesenchymal Stem Cells Promotes Malignant Progression in 3D-Bioprinted Models. ACS Appl Mater Interfaces. 2022;14:35344\u201356.","journal-title":"ACS Appl Mater Interfaces"},{"key":"7678_CR19","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1126\/science.1116447","volume":"309","author":"CA Cowan","year":"2005","unstructured":"Cowan CA, Atienza J, Melton DA, Eggan K. Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science. 2005;309:1369\u201373.","journal-title":"Science"},{"key":"7678_CR20","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/nature08752","volume":"463","author":"N Bhutani","year":"2010","unstructured":"Bhutani N, Brady JJ, Damian M, Sacco A, Corbel SY, Blau HM. Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature. 2010;463:1042\u20137.","journal-title":"Nature"},{"key":"7678_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, et al. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6:74.","journal-title":"Signal Transduct Target Ther"},{"key":"7678_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1140-6","volume":"9","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, Yi DY, Xue BZ, Wen WW, Lu YP, Abdelmaksou A, et al. CD90 determined two subpopulations of glioma-associated mesenchymal stem cells with different roles in tumour progression. Cell Death Dis. 2018;9:1101.","journal-title":"Cell Death Dis"},{"key":"7678_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13287-023-03285-9","volume":"14","author":"Z Peng","year":"2023","unstructured":"Peng Z, Wu Y, Wang J, Gu S, Wang Y, Xue B, et al. Development and validation of a glioma-associated mesenchymal stem cell-related gene prognostic index for predicting prognosis and guiding individualized therapy in glioma. Stem Cell Res Ther. 2023;14:56.","journal-title":"Stem Cell Res Ther"},{"key":"7678_CR24","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WM, Zheng S, Butler A, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573\u20133587.e29.","journal-title":"Cell"},{"key":"7678_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran D, Looney AP, Liu L, Wu E, Fong V, Hsu A, et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nature Immunol. 2019;20:163\u201372.","journal-title":"Nature Immunol"},{"key":"7678_CR26","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41587-020-00795-2","volume":"39","author":"R Gao","year":"2021","unstructured":"Gao R, Bai S, Henderson YC, Lin Y, Schalck A, Yan Y, et al. Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes. Nature Biotechnol. 2021;39:599\u2013608.","journal-title":"Nature Biotechnol"},{"key":"7678_CR27","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nchembio.687","volume":"7","author":"G Jia","year":"2011","unstructured":"Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang Y, et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol. 2011;7:885\u20137.","journal-title":"Nat Chem Biol"},{"key":"7678_CR28","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.ccell.2021.05.002","volume":"39","author":"T Hara","year":"2021","unstructured":"Hara T, Chanoch-Myers R, Mathewson ND, Myskiw C, Atta L, Bussema L, et al. Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma. Cancer Cell. 2021;39:779\u2013792.e11.","journal-title":"Cancer Cell"},{"key":"7678_CR29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson JT, Thorvaldsd\u00f3ttir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nature Biotechnol. 2011;29:24\u20136.","journal-title":"Nature Biotechnol"},{"key":"7678_CR30","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","volume":"178","author":"C Neftel","year":"2019","unstructured":"Neftel C, Laffy J, Filbin MG, Hara T, Shore ME, Rahme GJ, et al. An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma. Cell. 2019;178:835\u2013849.e21.","journal-title":"Cell"},{"key":"7678_CR31","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s13046-020-01706-8","volume":"39","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Geng X, Li Q, Xu J, Tan Y, Xiao M, et al. m6A modification in RNA: biogenesis, functions and roles in gliomas. J Exp Clin Cancer Res. 2020;39:192.","journal-title":"J Exp Clin Cancer Res"},{"key":"7678_CR32","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.molcel.2019.04.025","volume":"74","author":"H Shi","year":"2019","unstructured":"Shi H, Wei J, He C. Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers. Mol Cell. 2019;74:640\u201350.","journal-title":"Mol Cell"},{"key":"7678_CR33","doi-asserted-by":"publisher","first-page":"4618","DOI":"10.1038\/s41388-022-02457-w","volume":"41","author":"M Li","year":"2022","unstructured":"Li M, Xu H, Qi Y, Pan Z, Li B, Gao Z, et al. Tumor-derived exosomes deliver the tumor suppressor miR-3591-3p to induce M2 macrophage polarization and promote glioma progression. Oncogene. 2022;41:4618\u201332.","journal-title":"Oncogene"},{"key":"7678_CR34","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/nm.3337","volume":"19","author":"SM Pyonteck","year":"2013","unstructured":"Pyonteck SM, Akkari L, Schuhmacher AJ, Bowman RL, Sevenich L, Quail DF, et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med. 2013;19:1264\u201372.","journal-title":"Nat Med"},{"key":"7678_CR35","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1093\/nar\/gkw104","volume":"44","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Zeng P, Li YH, Zhang Z, Cui Q. SRAMP: prediction of mammalian N6-methyladenosine (m6A) sites based on sequence-derived features. Nucleic Acids Res. 2016;44:e91.","journal-title":"Nucleic Acids Res"},{"key":"7678_CR36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature12730","volume":"505","author":"X Wang","year":"2014","unstructured":"Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han D, et al. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature. 2014;505:117\u201320.","journal-title":"Nature"},{"key":"7678_CR37","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.stem.2012.08.013","volume":"11","author":"G Ren","year":"2012","unstructured":"Ren G, Zhao X, Wang Y, Zhang X, Chen X, Xu C, et al. CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNF\u03b1. Cell Stem Cell. 2012;11:812\u201324.","journal-title":"Cell Stem Cell"},{"key":"7678_CR38","doi-asserted-by":"publisher","first-page":"672928","DOI":"10.3389\/fonc.2021.672928","volume":"11","author":"X Cai","year":"2021","unstructured":"Cai X, Yuan F, Zhu J, Yang J, Tang C, Cong Z, et al. Glioma-Associated Stromal Cells Stimulate Glioma Malignancy by Regulating the Tumor Immune Microenvironment. Front Oncol. 2021;11:672928.","journal-title":"Front Oncol"},{"key":"7678_CR39","doi-asserted-by":"crossref","unstructured":"Khan F, Pang L, Dunterman M, Lesniak MS, Heimberger AB, Chen P. Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy. J Clin Invest. 2023;133:e163446.","DOI":"10.1172\/JCI163446"},{"key":"7678_CR40","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1158\/2159-8290.CD-15-0439","volume":"5","author":"M Greaves","year":"2015","unstructured":"Greaves M. Evolutionary determinants of cancer. Cancer Discov. 2015;5:806\u201320.","journal-title":"Cancer Discov"},{"key":"7678_CR41","doi-asserted-by":"publisher","first-page":"5025","DOI":"10.1007\/s13277-015-4337-7","volume":"37","author":"B Yan","year":"2016","unstructured":"Yan B, Wang J, Liu L. Chemotherapy promotes tumour cell hybridization in vivo. Tumour Biol. 2016;37:5025\u201330.","journal-title":"Tumour Biol"},{"key":"7678_CR42","doi-asserted-by":"publisher","first-page":"5360","DOI":"10.1158\/0008-5472.CAN-13-0896","volume":"73","author":"M Ramakrishnan","year":"2013","unstructured":"Ramakrishnan M, Mathur SR, Mukhopadhyay A. Fusion-derived epithelial cancer cells express hematopoietic markers and contribute to stem cell and migratory phenotype in ovarian carcinoma. Cancer Res. 2013;73:5360\u201370.","journal-title":"Cancer Res"},{"key":"7678_CR43","doi-asserted-by":"crossref","unstructured":"Melzer C, Ohe JV, Hass R. Altered Tumor Plasticity after Different Cancer Cell Fusions with MSC. Int J Mol Sci. 2020;21:8347.","DOI":"10.3390\/ijms21218347"},{"key":"7678_CR44","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1016\/j.celrep.2019.05.084","volume":"27","author":"YC Chen","year":"2019","unstructured":"Chen YC, Gonzalez ME, Burman B, Zhao X, Anwar T, Tran M, et al. Mesenchymal Stem\/Stromal Cell Engulfment Reveals Metastatic Advantage in Breast Cancer. Cell Rep. 2019;27:3916\u20133926.e5.","journal-title":"Cell Rep"},{"key":"7678_CR45","doi-asserted-by":"crossref","unstructured":"D\u00f6rnen J, Myklebost O, Dittmar T. Cell Fusion of Mesenchymal Stem\/Stromal Cells and Breast Cancer Cells Leads to the Formation of Hybrid Cells Exhibiting Diverse and Individual (Stem Cell) Characteristics. Int J Mol Sci. 2020;21:9636.","DOI":"10.3390\/ijms21249636"},{"key":"7678_CR46","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41392-020-00234-3","volume":"5","author":"B Tao","year":"2020","unstructured":"Tao B, Huang X, Shi J, Liu J, Li S, Xu C, et al. FTO interacts with FOXO3a to enhance its transcriptional activity and inhibits aggression in gliomas. Signal Transduct Target Ther. 2020;5:130.","journal-title":"Signal Transduct Target Ther"},{"key":"7678_CR47","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1158\/0008-5472.CAN-20-0132","volume":"80","author":"L Xiao","year":"2020","unstructured":"Xiao L, Li X, Mu Z, Zhou J, Zhou P, Xie C, et al. FTO Inhibition Enhances the Antitumor Effect of Temozolomide by Targeting MYC-miR-155\/23a Cluster-MXI1 Feedback Circuit in Glioma. Cancer Res. 2020;80:3945\u201358.","journal-title":"Cancer Res"},{"key":"7678_CR48","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nn.4185","volume":"19","author":"D Hambardzumyan","year":"2016","unstructured":"Hambardzumyan D, Gutmann DH, Kettenmann H. The role of microglia and macrophages in glioma maintenance and progression. Nature Neurosci. 2016;19:20\u20137.","journal-title":"Nature Neurosci"},{"key":"7678_CR49","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ccell.2017.06.003","volume":"32","author":"Q Wang","year":"2017","unstructured":"Wang Q, Hu B, Hu X, Kim H, Squatrito M, Scarpace L, et al. Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. Cancer Cell. 2017;32:42\u201356.e6.","journal-title":"Cancer Cell"},{"key":"7678_CR50","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/brain\/awz044","volume":"142","author":"J Behnan","year":"2019","unstructured":"Behnan J, Finocchiaro G, Hanna G. The landscape of the mesenchymal signature in brain tumours. Brain. 2019;142:847\u201366.","journal-title":"Brain"},{"key":"7678_CR51","doi-asserted-by":"crossref","unstructured":"Han D, He XY, Huang Y, Gao M, Guo T, Ren XH, et al. A Multifunctional Delivery System for Remodulating Cell Behaviors of Circulating Malignant Cells to Prevent Cell Fusion. Adv Sci. 2023;10:e2303309.","DOI":"10.1002\/advs.202303309"},{"key":"7678_CR52","doi-asserted-by":"publisher","first-page":"173090","DOI":"10.1016\/j.ejphar.2020.173090","volume":"877","author":"C Yunna","year":"2020","unstructured":"Yunna C, Mengru H, Lei W, Weidong C. Macrophage M1\/M2 polarization. Eur J Pharm. 2020;877:173090.","journal-title":"Eur J Pharm"},{"key":"7678_CR53","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.cell.2020.05.007","volume":"181","author":"F Klemm","year":"2020","unstructured":"Klemm F, Maas RR, Bowman RL, Kornete M, Soukup K, Nassiri S, et al. Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells. Cell. 2020;181:1643\u20131660.e17.","journal-title":"Cell"},{"key":"7678_CR54","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41423-023-01053-6","volume":"20","author":"A Silvin","year":"2023","unstructured":"Silvin A, Qian J, Ginhoux F. Brain macrophage development, diversity and dysregulation in health and disease. Cell Mol Immunol. 2023;20:1277\u201389.","journal-title":"Cell Mol Immunol"},{"key":"7678_CR55","doi-asserted-by":"crossref","unstructured":"Du Y, Wu S, Xi S, Xu W, Sun L, Yan J et al. ASH1L in Hepatoma Cells and Hepatic Stellate Cells Promotes Fibrosis-Associated Hepatocellular Carcinoma by Modulating Tumor-Associated Macrophages. Adv Sci. 2024;11:e2404756.","DOI":"10.1002\/advs.202404756"},{"key":"7678_CR56","doi-asserted-by":"crossref","unstructured":"Chen S, Zhang P, Zhu G, Wang B, Cai J, Song L, et al. Targeting GSDME-mediated macrophage polarization for enhanced antitumor immunity in hepatocellular carcinoma. Cell Mol Immunol. 2024;21:1505\u201321.","DOI":"10.1038\/s41423-024-01231-0"},{"key":"7678_CR57","doi-asserted-by":"publisher","first-page":"eabl8247","DOI":"10.1126\/sciadv.abl8247","volume":"8","author":"P Ji","year":"2022","unstructured":"Ji P, Gong Y, Jin ML, Wu HL, Guo LW, Pei YC, et al. In vivo multidimensional CRISPR screens identify Lgals2 as an immunotherapy target in triple-negative breast cancer. Sci Adv. 2022;8:eabl8247.","journal-title":"Sci Adv"},{"key":"7678_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02092-x","volume":"23","author":"S Cousin","year":"2024","unstructured":"Cousin S, Gu\u00e9gan JP, Shitara K, Palmieri LJ, Metges JP, Pernot S, et al. Identification of microenvironment features associated with primary resistance to anti-PD-1\/PD-L1\u2009+\u2009antiangiogenesis in gastric cancer through spatial transcriptomics and plasma proteomics. Mol Cancer. 2024;23:197.","journal-title":"Mol Cancer"},{"key":"7678_CR59","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41423-023-01061-6","volume":"20","author":"M Bied","year":"2023","unstructured":"Bied M, Ho WW, Ginhoux F, Bl\u00e9riot C. Roles of macrophages in tumor development: a spatiotemporal perspective. Cell Mol Immunol. 2023;20:983\u201392.","journal-title":"Cell Mol Immunol"},{"key":"7678_CR60","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/ni.3324","volume":"17","author":"F Ginhoux","year":"2016","unstructured":"Ginhoux F, Schultze JL, Murray PJ, Ochando J, Biswas SK. New insights into the multidimensional concept of macrophage ontogeny, activation and function. Nat Immunol. 2016;17:34\u201340.","journal-title":"Nat Immunol"},{"key":"7678_CR61","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.immuni.2019.05.003","volume":"50","author":"SA Mariani","year":"2019","unstructured":"Mariani SA, Li Z, Rice S, Krieg C, Fragkogianni S, Robinson M, et al. Pro-inflammatory Aorta-Associated Macrophages Are Involved in Embryonic Development of Hematopoietic Stem Cells. Immunity. 2019;50:1439\u20131452.e5.","journal-title":"Immunity"},{"key":"7678_CR62","doi-asserted-by":"crossref","unstructured":"van der Zande HJP, Nitsche D, Schlautmann L, Guigas B, Burgdorf S. The Mannose Receptor: From Endocytic Receptor and Biomarker to Regulator of (Meta)Inflammation. Front Immunol. 2021;12:765034.","DOI":"10.3389\/fimmu.2021.765034"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07678-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07678-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07678-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T11:03:46Z","timestamp":1745665426000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07678-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,26]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7678"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07678-x","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,26]]},"assertion":[{"value":"23 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Institutional Ethics Committee of Tongji Medical College, Huazhong University of Science and Technology. Approval number: [2019] IEC (8561). The animal study complies with NIH animal care guidelines, and was approved by the Institutional Animal Care and Use Committee of Huazhong University of Science and Technology. Approval number: [2022] IACUC (3854).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"345"}}